• Home
  • >
  • Nath Bio Genes India Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/n.svg Logo

Nath Bio Genes India Ltd Financial Statement

Nath Bio Genes India Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue44.4234.2722.63
Operating Expense38.5625.9517.48
Net Profit3.213.961.6
Net Profit Margin7.2311.567.07
Earning Per Share2.182.090.85
EBIDTA5.878.335.15
Effective Tax Rate10.569.256.8

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Nath Bio Genes India Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Total Revenue Annual301.36278.36
Operating Expenses Annual252.62241.17
Operating Profit Annual49.3-49.74
Interest Annual10.1210.61
Depreciation1.371.48
Net Profit Annual35.03-67.38
Tax Annual1.153.95

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Nath Bio Genes India Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Cash Flow at the Beginning4.1829.22
Cash Flow from Operations38.3717.05
Cash Flow from Investing-2.88-19.85
Cash Flow from Financing-1.67-22.23
Cash Flow at the End384.18

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Nath Bio Genes India Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
PBDIT Margin (%)16.3914.04
PBIT Margin (%)15.3912.93
PBT Margin (%)13.8811.72
Net PROFIT Margin (%)11.67-24.19
Return On Networth / Equity (%)6.284.38
Return On Networth /Employed(%)7.035.64
Return On Assets (%)5.37-10.64
Total Debt / Equity(X)0.180.17
Asset Turnover Ratio (%)0.460.44

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Nath Bio Genes India Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022
Fixed Assets Annual244.38244.89
Total Current Assets Annual520.83467.77
Non Current Assets Annual271.97271.72
Total Shareholders Funds Annual573.17541.93
Total Assets Annual792.8739.49

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Nath Bio Genes India Ltd Earning Calls
Mar 2024
EPS beaten by 35.51 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Nath Bio Genes India Ltd has a market capitalization of 330.19 Cr. Value Research classifies it as a Small-Cap company.

Yes, Nath Bio Genes India Ltd is debt-free with a debt-to-equity ratio of 0.18.

In FY 2023, Nath Bio Genes India Ltd recorded a total revenue of approximately 332.62 Cr marking a significant milestone in the company's financial performance.

Nath Bio Genes India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Nath Bio Genes India Ltd's current PE ratio is 8.33.

Nath Bio Genes India Ltd's ROCE averaged 6.5% from the FY ending March 2022 to 2024, with a median of 6.8%. It peaked at 7.0% in March 2024, reflecting strong capital efficiency over the period..

Nath Bio Genes India Ltd's latest EBIT is Rs. 50.67 Cr, surpassing the average EBIT of Rs. 14.71 Cr over the 5 years..